Single User License
INR 170050
Site License
INR 340100
Corporate User License
INR 510150

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Chronic Stable Angina Global Clinical Trials Review, H1

Chronic Stable Angina Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Chronic Stable Angina Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Chronic Stable Angina Global Clinical Trials Review, H1, 2015" provides an overview of Chronic Stable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Stable Angina. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Chronic Stable Angina 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Chronic Stable Angina to Cardiovascular Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Chronic Stable Angina to Cardiovascular Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Chronic Stable Angina 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Chronic Stable Angina Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

Gilead Sciences, Inc. 32

Clinical Trial Overview of Gilead Sciences, Inc. 32

Tasly Pharmaceuticals, Inc. 33

Clinical Trial Overview of Tasly Pharmaceuticals, Inc. 33

Lacer, S.A. 34

Clinical Trial Overview of Lacer, S.A. 34

Chong Kun Dang Pharmaceutical Corp. 35

Clinical Trial Overview of Chong Kun Dang Pharmaceutical Corp. 35

Les Laboratoires Servier SAS 36

Clinical Trial Overview of Les Laboratoires Servier SAS 36

Mylan N.V. 37

Clinical Trial Overview of Mylan N.V. 37

ICON Plc 38

Clinical Trial Overview of ICON Plc 38

GlaxoSmithKline Plc 39

Clinical Trial Overview of GlaxoSmithKline Plc 39

Boehringer Ingelheim GmbH 40

Clinical Trial Overview of Boehringer Ingelheim GmbH 40

Billev Pharma ApS 41

Clinical Trial Overview of Billev Pharma ApS 41

Clinical Trial Overview of Top Institutes / Government 42

University of Dundee 42

Clinical Trial Overview of University of Dundee 42

Institut de Recherches Internationales Servier 43

Clinical Trial Overview of Institut de Recherches Internationales Servier 43

University of Glasgow 44

Clinical Trial Overview of University of Glasgow 44

Agostino Gemelli University Polyclinic 45

Clinical Trial Overview of Agostino Gemelli University Polyclinic 45

Asan Medical Center 46

Clinical Trial Overview of Asan Medical Center 46

Brigham and Women's Hospital 47

Clinical Trial Overview of Brigham and Women's Hospital 47

Campus Bio-Medico University Rome 48

Clinical Trial Overview of Campus Bio-Medico University Rome 48

Chengdu University of Traditional Chinese Medicine 49

Clinical Trial Overview of Chengdu University of Traditional Chinese Medicine 49

Duke University 50

Clinical Trial Overview of Duke University 50

Fu Wai Hospital, CAMS & PUMC 51

Clinical Trial Overview of Fu Wai Hospital, CAMS & PUMC 51

Five Key Clinical Profiles 52

Appendix 71

Abbreviations 71

Definitions 71

Research Methodology 72

Secondary Research 72

About GlobalData 73

Contact Us 73

Disclaimer 73

Source 74

List of Figures

Chronic Stable Angina Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Chronic Stable Angina Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Chronic Stable Angina Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Chronic Stable Angina Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Chronic Stable Angina Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Chronic Stable Angina Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Chronic Stable Angina to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Chronic Stable Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Chronic Stable Angina Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Chronic Stable Angina to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Chronic Stable Angina Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Chronic Stable Angina Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Chronic Stable Angina Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Chronic Stable Angina Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Chronic Stable Angina Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Chronic Stable Angina Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Chronic Stable Angina Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Chronic Stable Angina Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Chronic Stable Angina Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Chronic Stable Angina Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Chronic Stable Angina Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

GlobalData Methodology 72

List of Tables

Chronic Stable Angina Therapeutics, Global, Clinical Trials by Region, 2015* 7

Chronic Stable Angina Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Chronic Stable Angina Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Chronic Stable Angina Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Chronic Stable Angina Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Chronic Stable Angina Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Chronic Stable Angina Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Chronic Stable Angina Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Chronic Stable Angina to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Chronic Stable Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Chronic Stable Angina Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Chronic Stable Angina to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Chronic Stable Angina Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Chronic Stable Angina Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Chronic Stable Angina Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Chronic Stable Angina Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Chronic Stable Angina Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Chronic Stable Angina Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Chronic Stable Angina Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Chronic Stable Angina Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Chronic Stable Angina Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Chronic Stable Angina Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Chronic Stable Angina Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Chronic Stable Angina Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Chronic Stable Angina Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 32

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Tasly Pharmaceuticals, Inc., 2015* 33

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Lacer, S.A., 2015* 34

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Chong Kun Dang Pharmaceutical Corp., 2015* 35

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Laboratoires Servier SAS, 2015* 36

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan N.V., 2015* 37

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by ICON Plc, 2015* 38

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 39

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2015* 40

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Billev Pharma ApS, 2015* 41

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2015* 42

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2015* 43

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Glasgow, 2015* 44

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Agostino Gemelli University Polyclinic, 2015* 45

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 46

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2015* 47

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Campus Bio-Medico University Rome, 2015* 48

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu University of Traditional Chinese Medicine, 2015* 49

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 50

Chronic Stable Angina Therapeutics Clinical Trials Market, Global, Clinical Trials by Fu Wai Hospital, CAMS & PUMC, 2015* 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Gilead Sciences, Inc.

Tasly Pharmaceuticals, Inc.

Lacer, S.A.

Chong Kun Dang Pharmaceutical Corp.

Les Laboratoires Servier SAS

Mylan N.V.

ICON Plc

GlaxoSmithKline Plc

Boehringer Ingelheim GmbH

Billev Pharma ApS

Chronic Stable Angina Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Chronic Stable Angina, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com